Anti‐tumor and cardiotoxic effects of microtubule polymerization inhibitors: The mechanisms and management strategies
Journal of Applied Toxicology · 2024
DOI: 10.1002/jat.4521 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Applied Toxicology, 2024. Verfasst von Ryota Tochinai und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Pathophysiology and Animal Health, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Neoplasms, Antineoplastic Agents, Heart Diseases. Die Arbeit nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yukiko Kuwata.
Abstract (Originalsprache)
Microtubule polymerization inhibitors (MPIs) have long been used as anticancer agents because they inhibit mitosis. Microtubules are thought to play an important role in the migration of tumor cells and the formation of tumor blood vessels, and new MPIs are being developed. Many clinical trials of novel MPIs have been conducted in humans, while some clinical studies in dogs have also been reported. More attempts to apply MPIs not only in humans but also in the veterinary field are expected to be made in the future. Meanwhile, MPIs have a risk of cardiotoxicity. In this paper, we review findings on the pharmacological effects and cardiotoxicity of MPIs, as well as the mechanisms of their cardiotoxicity. Cardiotoxicity of MPIs involves not only the direct effects of MPIs on cardiomyocytes but also their effects on vascular function. For example, hypertension induced by impaired vascular function also contributes to the exacerbation of myocardial damage, and blood pressure control may be useful in reducing cardiotoxicity. By combined administration of MPIs and other anticancer agents, MPI efficacy may be enhanced, thereby potentially allowing to keep MPI dosage low. Measurement of myocardial injury markers in blood and echocardiography may be useful for monitoring cardiotoxicity. In particular, two‐dimensional speckle tracking may have high sensitivity for the early detection of MPI‐induced cardiac dysfunction. The exploration of the potential of new MPIs while understanding their toxicity and how to deal with them will lead to the further development of cancer chemotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Veterinary Pathophysiology and Animal Health, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan.
ORCID-Profile: Ryota Tochinai
Förderung
- Yukiko Kuwata
Zitieren
APA
Tochinai, R., Nagashima, Y., Sekizawa, S. I., & Kuwahara, M. (2024). Anti‐tumor and cardiotoxic effects of microtubule polymerization inhibitors: The mechanisms and management strategies. Journal of Applied Toxicology. https://doi.org/10.1002/jat.4521
Vancouver
Tochinai R, Nagashima Y, Sekizawa SI, Kuwahara M. Anti‐tumor and cardiotoxic effects of microtubule polymerization inhibitors: The mechanisms and management strategies. Journal of Applied Toxicology. 2024. doi:10.1002/jat.4521
BibTeX
@article{Tochinai2024,
author = {Tochinai, Ryota and Nagashima, Yoshiyasu and Sekizawa, Shin-Ichi and Kuwahara, Masayoshi},
title = {Anti‐tumor and cardiotoxic effects of microtubule polymerization inhibitors: The mechanisms and management strategies},
journal = {Journal of Applied Toxicology},
year = {2024},
doi = {10.1002/jat.4521}
}
EUVIMED